Institutional investors purchased a net $567.5 thousand shares of TTNP during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 13.51% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE MUNICIPAL EMPLOYEES' RETIREM... Bought 303.3 Thousand shares of Titan Pharmaceuticals Inc